NDA West Nile team Sensitizing drug shop operators during s meeting at Zawadi hotel in Adjumani
Manager Southwestern region Farida Khaukha addressing participants at Stakeholder’s sensitization meeting at Rwizi Arch hotel Mbarara
3th Steering Committee of the EAC MRH Programme held in Dar es Salaam Tanzania. The programme is aimed at improving access to safe, efficacious and good quality essential medicines and to standardize approaches in medicines regulation in the region.
Valsartan is a drug used in the treatment of high blood pressure, usually in combination with other anti-hypertensive drugs. It has been discovered that some brands of this drug were manufactured using an ingredient potentially contaminated with an impurity called N-nitrosodimethylamine (NDMA), which is classified as a probable human carcinogen (a substance that could cause…Details
National Drug Authority wishes to inform you that retention of Human and Veterinary products on the drug register for financial year 2018 / 2019 will run from 1st July, 2018 to 1st September 2018. All products that will not have been retained by then will not appear on the monthly drug registers. Retention invoices will…Details
Official Response of the National Drug Authority (NDA) to a petition by Mark Kamanzi, the interdicted former Head of Legal Services, National Drug Authority to the IGG
The National Drug Authority (NDA) has learnt of a story in the Daily Monitor of Saturday 30th June 2018, titled: IGG Probes NDA Officials over Abuse of Office. The story stems from yet another petition by Mr. Mark Kamanzi, the interdicted former Head, Legal Services alleging “abuse of office and causing financial loss to the…Details